NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

IVD用AI市場

Artificial Intelligence Markets in IVD

出版商 Kalorama Information 商品編碼 935828
出版日期 內容資訊 英文 71 Pages
商品交期: 最快1-2個工作天內
價格
IVD用AI市場 Artificial Intelligence Markets in IVD
出版日期: 2020年04月07日內容資訊: 英文 71 Pages
簡介

臨床醫學領域的人工智慧,過去數年實現了驚異性的進步。許多產品於臨床用途的認可,新的許多研究用途專用應用進入市場,還有更多幀處於開發過程中。近幾年,診斷相關企業以提高患者照護的資料分析的能力為目標,協助AI企業,開始實現日益先進的機器學習技術。

本報告提供體外診斷 (IVD) 用AI的市場調查,市場定義和概要,FDA的支援,對COVID-19的措施,企業、研究機關、大學等的各領域的各種配合措施,市場規模估計、預測等資料彙整。

第1章 摘要整理

第2章 診斷市場上AI

  • 臨床現場的AI
  • 主要的AI為基礎的舉措、合作、實驗
  • 血型和篩檢
  • 癌症
  • 心臟病
  • 遺傳學的檢驗
  • GRAIL
  • 血糖監測系統
  • 血液學
  • 組織學
  • IT
  • 腎臟病
  • 液體活體組織切片
  • 微生物學
  • 微生物
  • 分子診斷
  • 次世代定序
  • 寄生蟲學
  • 病理學
  • 移植風險試驗
  • 尿液檢查
  • 未來展望

第3章 市場分析:診斷中的AI

  • 市場規模估計、預測
  • 市場估計:各用途
  • 市場估計:各零件
目錄
Product Code: 20-037

The past few years has seen extraordinary advances in artificial intelligence (AI) in clinical medicine. More products have been cleared for clinical use, more new research-use-only applications have come to market and many more are in development. In recent years, diagnostics companies - in collaboration with AI companies - have begun implementing increasingly sophisticated machine learning techniques to improve the power of data analysis for patient care. The goal is to use developed algorithms to standardize and aid interpretation of test data by any medical professional irrespective of expertise. This way AI technology can assist pathologists, laboratorians and clinicians in complex decision-making. This report examines selected AI-based initiatives, collaborations and tests in various in vitro diagnostic (IVD) market segments.

‘Artificial Intelligence Markets in IVD’ contains the following important data points:

  • The Market for AI in Diagnostics, 2019
  • Forecasted Market for 2024
  • Breakout of Market by Application, 2019 (Glucose, Histology, Microbiology, Hematology, Biomarker Diagnostic Aids)
  • Breakout of Market by Components, 2019 (Hardware, Software, Services)
  • Significant Partnerships and Initiatives in AI Related to In Vitro Diagnostics

Digital pathology products and diabetes management devices were the first to come to market with data interpretation applications. The last few years have seen the use of AI interpretation apps extended to a broader range of products including microbiology, disease genetics and cancer precision medicine. This report will review some of the AI-linked tests and test services that have come to market and others that are in development in some of the following market segments:

  • Cancer Diagnostics
  • Cardiac Disease Testing
  • Digital Pathology
  • Genetic Testing
  • Glucose Monitoring
  • Hematology
  • Histology
  • Information Technology (including Electronic Medical Records)
  • Liquid Biopsy
  • Microbiology
  • Microbiome
  • Molecular Diagnostics
  • Next-Generation Sequencing
  • Point of Care
  • Transplant Risk Testing
  • Urinalysis

Applications of AI are evolving that predict outcomes such as diagnosis, death or hospital readmission; that improve upon standard risk assessment tools; that elucidate factors that contribute to disease progression; or that advance personalized medicine by predicting a patient's response to treatment. AI tools are in use and in development to review data and to uncover patterns in the data that can be used to improve analyses and uncover inefficiencies. Many enterprises are joining this effort.

The following are among the companies and institutions whose innovations are featured in ‘Artificial Intelligence Markets in IVD’:

  • Adaptive Biotechnologies
  • ARUP Laboratories
  • Bay Echo Labs
  • BGI Genomics
  • Biofourmis Singapore Pte. Ltd.
  • CareDX
  • Caris Life Sciences
  • Case Western Reserve University
  • Clever Culture Systems
  • CompCyst
  • Copan Diagnostics
  • Curetis Group
  • Diagnomics
  • DNAnexus
  • Eko
  • Euroclone Diagnostica
  • Flagship Biosciences
  • Freenome
  • Genomenon
  • GenomeSmart
  • Gilead
  • Gnosis Data Analysis
  • Google
  • Grail
  • Ibex Medical
  • IBM Watson Health
  • Individumed
  • Inspirata
  • Institut Curie
  • IntegraGen
  • IQVIA
  • Johns Hopkins
  • LabCorp
  • LungLife AI
  • Maxwell Plus
  • Medtronic
  • Nikon Instruments
  • OPTiM
  • Oxford Nanopore
  • Paragon Genomics
  • PathAI
  • Pathway Genomics
  • Persivia
  • Phase Genomics
  • Philips
  • Predicine
  • PredictImmune
  • Predigraft
  • Qiagen
  • Rady Children's Institute for Genomic Medicine
  • Reliant Immune Diagnostics
  • RenalytixAI
  • Seegene
  • Siemens Healthineers
  • Sophia Genetics
  • Surgisphere Corporation
  • Sysmex
  • UgenTec
  • Viome
  • Xifin

TABLE OF CONTENTS

1: EXECUTIVE SUMMARY

  • THE ARTIFICIAL INTELLIGENCE BOOM
  • THE FDA IS GETTING READY
    • FDA Awards DNAnexus Contract to Power precisionFDA Collaborative Omics Environment in COVID-19 AND ARTIFICIAL INTELLIGENCE
    • Deep Learning to Discover Origins of COVID-19
    • AI-Assisted App Will Direct Individuals Most At Risk for Having COVID-19
    • FDA Allows Remote Use of Philips IntelliSite Pathology Solution during COVID Crisis
    • JLK Inspection: RT-PCR COVID-19 Testing with AI-Enhanced Imaging Aid
    • Persivia: Ruleset to Triage COVID-19 Testing
    • Surgisphere Rapid Test Uses AI to Diagnose COVID-19
    • Biofourmis' AI-Powered Remote Monitoring Platform to Fight COVID-19
  • METHODOLOGY

2: ARTIFICIAL INTELLIGENCE IN DIAGNOSTICS MARKETS

  • AI IN CLINICAL PRACTICE
  • SELECTED AI-BASED INITIATIVES / COLLABORATIONS / TESTS
    • Table 2-1: Selected AI-based Initiatives / Collaborations / Tests
    • IBM Watson Health
  • BLOOD TYPING AND SCREENING
  • CANCER
    • Freenome: Computational Biology and Machine Learning for Cancer Detection
    • CompCyst: Big Increase in Identification of Benign Cysts
    • Grail: Machine Learning on Cancer Mutations
    • Lung Cancer Diagnostics - LungLife AI
  • CARDIAC DISEASE
    • Eko's AFib and Heart Murmur Detection Algorithms
    • Machine Learning to Assess the Likelihood of Acute Myocardial Infarction
    • Bay Echo Labs: FDA-cleared EF Calculation
  • GENETIC TESTING
  • GRAIL
    • Rady Children's Institute for Genomic Medicine
    • Pathway Genomics
  • GLUCOSE MONITORING
    • Medtronic's Guardian Connect CGM System
    • University of Warwick Develops A.I. Technology for Tracking Blood Glucose
  • HEMATOLOGY
  • HISTOLOGY
    • PathAI and Gilead Evaluating Machine Learning Approaches to Liver Histology Assessment
  • INFORMATION TECHNOLOGY
  • Google
    • Electronic Medical Records: Predictive Analytics and AI
  • KIDNEY DISEASE
    • KidneyIntelX: Improved Kidney Testing
  • LIQUID BIOPSY
  • MICROBIOLOGY
  • MICROBIOME
    • Viome
  • MOLECULAR DIAGNOSTICS
    • Seegene: AI-Inspired Molecular Diagnostics
    • Predicine and Flagship Biosciences Collaborate
    • Molecular Colorectal Diagnosis
  • NEXT-GENERATION SEQUENCING
    • Siemens
    • Curetis Group Company Launches AI-powered Molecular Antibiotic Susceptibility Test
    • Oxford Nanopore
    • BGI Genomics
    • Qiagen
  • PARASITOLOGY
    • ARUP-Techcyte: Detection of Parasites and Ova
  • PATHOLOGY
    • LabCorp and Philips Collaborate
  • POINT OF CARE
    • Siemens Strengthens Technology Position in Immunoassay Point-of-Care Testing
    • Reliant Immune Diagnostics: In-Home Rapid Diagnostic Screening Using AI
  • TRANSPLANT RISK TESTING
    • CareDX and Predigraft
  • URINALYSIS
    • Clever Culture: FDA Cleared Automation of Sample Interpretation
  • WHAT THE FUTURE HOLDS

3: MARKET ANALYSIS: ARTIFICIAL INTELLIGENCE IN DIAGNOSTICS

  • SIZE AND FORECAST ESTIMATE
    • Figure 3-1: AI in Diagnostics Estimated Market and Forecast, 2019-2024 ($M)
  • MARKET BY APPLICATION
    • Figure 3-2: Artificial Intelligence Market in Diagnostics: Market Estimate by Application (Histology-based AI, Microbiology, Hematology, Glucose Testing, Biomarker Diagnostic Aids) (%)
  • COMPONENT MARKET ANALYSIS
    • Table 3-1: Artificial Intelligence Market in Diagnostics: Market by Component, 2019 (Hardware, Software, Services) ($M, %)